The two highest dose groups also exhibited improvement in lung function (percentage of predicted FVC and diffusing capacity of the lungs for carbon monoxide, DLCO) that did not reach statistical significance but was maintained throughout all time intervals of the study [ 128 ].
← all excerpts
Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.
1
—
—